Skip to main content
. 2020 Nov 3;2020(11):CD003229. doi: 10.1002/14651858.CD003229.pub4

4. Results by pharmacological group: Centella asiatica.

Variables Dichotomous Continuous
Heaviness NS
Global assessment by the participant RR 0.28 (0.14 to 0.57)
Adverse events NS
Note: Only 1 study was analyzed

NS: non‐significant
RR: risk ratio